(Updated - September 29, 2021 4:15 PM EDT)

Stifel analyst Bradley Canino initiates coverage on Affimed Therapeutics (NASDAQ: AFMD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE